Zobrazeno 1 - 10
of 264
pro vyhledávání: '"AK Ng"'
Autor:
Pg, Natali, Cavaliere R, Bigotti A, Nicotra MR, Russo C, Ak, Ng, Patrizio Giacomini, Ferrone S
Publikováno v:
Scopus-Elsevier
Europe PubMed Central
Europe PubMed Central
The antigenic heterogeneity of primary and metastatic lesions surgically removed from nine patients with nodular melanoma was investigated by using monoclonal antibodies to HLA-A, B antigens, to beta 2-microglobulin, to Ia antigens, and to melanoma-a
Publikováno v:
Europe PubMed Central
Surgically removed normal and malignant mammary tissues and human breast carcinoma cell lines were tested in binding assays with monoclonal antibodies to HLA-A,B,C antigens, beta 2-microglobulin, HLA-DR antigens, and tumor-associated antigens; the la
Publikováno v:
Europe PubMed Central
Using monoclonal antibodies to distinct determinants of a human high-molecular weight melanoma-associated antigen (HMW-MAA), a double determinant immunoassay has been developed. The assay is specific and reproducible. Its sensitivity is influenced by
Role of radiation therapy in the treatment of stage I/II mucosa-associated lymphoid tissue lymphoma.
Publikováno v:
Annals of Oncology. Apr2007, Vol. 18 Issue 4, p672-672. 1p.
Autor:
Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Frigault MJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Hematological oncology [Hematol Oncol] 2025 Jan; Vol. 43 (1), pp. e70025.
Autor:
Ng PY; Department of Adult Intensive Care Queen Mary Hospital Hong Kong SAR China.; Critical Care Medicine Unit, School of Clinical Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong SAR China., Ng AK; Department of Medicine, Queen Mary Hospital The University of Hong Kong Hong Kong SAR China., Ip A; Critical Care Medicine Unit, School of Clinical Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong SAR China., Sin WC; Department of Adult Intensive Care Queen Mary Hospital Hong Kong SAR China.; Critical Care Medicine Unit, School of Clinical Medicine, Li Ka Shing Faculty of Medicine The University of Hong Kong Hong Kong SAR China., Yiu KH; Department of Medicine, Queen Mary Hospital The University of Hong Kong Hong Kong SAR China.; Division of Cardiology, Department of Medicine The University of Hong Kong-Shenzhen Hospital Shen Zhen China.
Publikováno v:
Journal of the American Heart Association [J Am Heart Assoc] 2024 Dec 24, pp. e037207. Date of Electronic Publication: 2024 Dec 24.
Autor:
Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Frigault MJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Jacobson CA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
American journal of hematology [Am J Hematol] 2024 Sep; Vol. 99 (9), pp. 1837-1840. Date of Electronic Publication: 2024 Jun 11.
Autor:
Ng PY; Critical Care Medicine Unit, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Adult Intensive Care, Queen Mary Hospital, Hong Kong SAR, China., Ip A; Critical Care Medicine Unit, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Ng AK; Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China., Sin SW; Critical Care Medicine Unit, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Adult Intensive Care, Queen Mary Hospital, Hong Kong SAR, China., Chan JF; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China.; Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China., To KK; State Key Laboratory for Emerging Infectious Diseases, Carol Yu Centre for Infection, Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.; Department of Microbiology, Queen Mary Hospital, Pokfulam, Hong Kong SAR, China.; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Sha Tin, Hong Kong SAR, China.; Department of Infectious Disease and Microbiology, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong, China., Yap DY; Division of Nephrology, Department of Medicine, School of Clinical Medicine, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2024 Mar 14; Vol. 70, pp. 102535. Date of Electronic Publication: 2024 Mar 14 (Print Publication: 2024).
Autor:
Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Frigault MJ; Division of Hematology & Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3243. Date of Electronic Publication: 2023 Dec 16.
Autor:
Ababneh HS; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Ng AK; Department of Radiation Oncology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Abramson JS; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Soumerai JD; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Takvorian RW; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Frigault MJ; Division of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA., Patel CG; Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Hematological oncology [Hematol Oncol] 2024 Jan; Vol. 42 (1), pp. e3231. Date of Electronic Publication: 2023 Oct 05.